Oncology, ophthalmology, and pegfilgrastim biosimilars reached 81% market share within five years, while others lagged at 26%. CMS increased biosimilar reimbursement to ASP plus 8% of the ...

EnergyBin, an exchange platform for secondary market solar panels in the United States, has released its annual pricing and trends report. The company facilitates direct trading between buyers and ...